Pune, Maharashtra -- (SBWIRE) -- 05/24/2019 -- According to Fact.MR's recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period (2017-2026). Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026-end.

Dual Chamber Prefilled Syringes – Efficient Solution for Reconstituting Lyophilized Drugs during Administration

There has been an incessant requirement for reconstituting the lyophilized drugs during their administration, along with growing necessity of tackling potential compliance and safety issues associated with the reconstitution. This has further led to the development of syringes that are capable of curtailing number of steps required for the reconstitution of drugs and making them available for injection. Dual chamber prefilled syringes are the most efficient solution to cater this requirement, as they enable immediate reconstitution within the syringe just prior to injection. Dual chamber prefilled syringes seek widespread utilization in storing biological substances and active pharmaceutical components, which cannot retain their stability for extended duration. These devices enable elimination of drug loss through maintenance of the drugs' sterility prior to injection. Advancements in technology have resulted into improvements in the arrangement of liquid components in the syringes and injectors, while attracting more patients in opting for these efficient & safe syringes.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=486 

Lyophilized drugs have represented a robust penetration worldwide in the recent past. Lyophilized drugs account for largest share of all reconstitution-requiring injectable/infusible drugs. As a large number of injectable/infusible drugs have been developed for self-administration, special challenges are incurred for the drug developers. However, dual chamber prefilled syringes, which are particularly designed for simplifying reconstitution devoid of patient handling of diluent or drug, have become the mainstay option for delivering these drugs, meanwhile curtailing challenges faced by developers. With lyophilized drugs witnessing proliferated penetration, demand for dual chamber prefilled syringes will gain a significant upsurge in the foreseeable future.

5 Key Takeaways from Fact.MR's Report on Dual Chamber Prefilled Syringes Market for Forecast Period 2017-2026

Sales of dual chamber prefilled syringes are expected to record the fastest expansion in online pharmacies through 2026, trailed by retail pharmacies that will account for a relatively larger market revenue share than online pharmacies by 2026-end.
In terms of revenues, hospital pharmacies will continue to be the leading contributor to the global dual chamber prefilled syringes market.
Based on product material, glass prefilled syringes are anticipated to remain sought-after in the market, with sales projected to exceed US$ 2,000 Mn in revenues by 2026-end. Plastic prefilled syringes will exhibit a relatively higher CAGR in the market through 2026.
On the basis of product type, conventional prefilled syringes are expected to account for the lion's share of the market during 2017 to 2026. Safety prefilled syringes will account for nearly 30% revenue share of the market through the forecast period.
North America is likely to prevail as the fast-expanding as well as the most lucrative market for dual chamber prefilled syringes, followed by Europe. Asia-Pacific excluding Japan (APEJ) will also account for a major chunk of the market's revenue share during the forecast period.
Browse Full Report @ https://www.factmr.com/report/486/dual-chamber-prefilled-syringes-market 

With trends of surging demand for self-injection syringes, and the development of advanced dual chamber prefilled syringes, major players in the market have directed their concentration toward product portfolio expansion. In this rapidly evolving and highly competitive market, several players are emphasizing on essentiality of the up-to-date information, in a bid to monitor their performance and make critical decisions apropos to profitability & growth. Few market players are also focusing on improvements in design of the dual chamber prefilled syringes in order to enhance the stability as well as safety of various sensitive drugs. Key players actively underpinning the market growth, as profiled by Fact.MR's report, include Pfizer Inc., Amgen Inc., Boehringer Ingelheim GmbH, Nipro Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, Gerresheimer AG, Ypsomed Holding AG, West Pharmaceutical Services, Inc., Schott AG, Otsuka America Pharmaceutical, Inc., Credence MedSystems, Inc., Catalent, Inc., and Bespak Europe Ltd.

You can Buy This Report from Here @ https://www.factmr.com/checkout/486/S 

To deliver a seamless understanding of the Dual Chamber Prefilled Syringes market, the report is divided into 18 sophisticated chapters whose snapshots are provided below.

Chapter 1 – Executive Summary
The report commences with the chapter of the executive summary which delivers brief yet affluent information of the Dual Chamber Prefilled Syringes market. The chapter includes discussion on the market overview, market analysis and market recommendations regarding the Dual Chamber Prefilled Syringes market derived based on Fact.MR's proprietary wheel of fortune.

Chapter 2 – Market Introduction
In the market introduction chapter, the Dual Chamber Prefilled Syringes market is introduced along with the
market segmentation in the form of market taxonomy. The chapter also introduces the Dual Chamber Prefilled Syringes in the market definition section.

Chapter 3 - Dual Chamber Prefilled Syringes Market Background
In this chapter, macroeconomic factors, market dynamics, a complete value chain and pricing
analysis with regard to Dual Chamber Prefilled Syringes market is elaborately discussed. Discussion on the
market drivers, restraints, trends and opportunities and their impact on the market forecast is also
covered in this chapter.

Chapter 4 - Global Dual Chamber Prefilled Syringes Market Analysis 2013–2017 and Forecast 2018–2026
This chapter provides the Dual Chamber Prefilled Syringes market size in terms of market volume and value
during the forecast period. Market analysis based on absolute $ opportunity and y-o-y growth of the Dual Chamber Prefilled Syringes market is also covered in this chapter.

Chapter 5 - Global Dual Chamber Prefilled Syringes Market Analysis 2013–2017 and Forecast 2018–2026,

By System Type Based on system types in the Dual Chamber Prefilled Syringes market, the chapter elaborates market size of individual systems and analysis by system types and summary of this section is covered in the chapter.

Chapter 6 - Global Dual Chamber Prefilled Syringes Market Analysis 2013–2017 and Forecast 2018–2026, By Application

Based on applications, Market size of individual applications, their market attractiveness analysis and summary are also covered.

Chapter 7 - Global Dual Chamber Prefilled Syringes Market Analysis 2013–2017 and Forecast 2018–2026, By End User

This chapter elaborates the segmentation of the Dual Chamber Prefilled Syringes market based on end users
including independent end users, Market attractive analysis by end users is also discussed to fathom relative lucrativeness of different end users of the Dual Chamber Prefilled Syringes market.

Chapter 8 - Global Dual Chamber Prefilled Syringes Market Analysis 2013–2017 and Forecast 2018–2026, By Region

With the geographical perspective, the Dual Chamber Prefilled Syringes market is analyzed on a total of seven regions including North America, Latin America, Europe, South East Asia & Pacific, Middle East & Africa, China and Japan. Historical data and prevailing trends in the Dual Chamber Prefilled Syringes market and their influence on the global market performance is discussed in this chapter.

And Continue....